Debio0123

· Debiopharm

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Debio0123, covering 2025-12-05 to 2025-12-05. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study to Evaluate Debio0123 + Sacituzumab Govitecan Combination in TNBC or HR+/HER2- Advanced Breast Cancer [Phase 1, Phase 2]

See pricing